Loading
Every dated change on the records linked to Limited-stage small-cell lung cancer, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Median survival 23 against 19 months (p=0.
Relative risk of death 0.
A milestone in how this cancer is treated.